Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis

  • Glaspole, Ian (Primary Chief Investigator (PCI))
  • Symons, Karen M. (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date18/06/2131/12/24

Keywords

  • Lung diseases
  • Pulmonary fibrosis
  • Clinical trial